购物车
- 全部删除
您的购物车当前为空
Anti-GLA/alpha-Galactosidase A Antibody (4R472)
还可以产品编号 TMAY-02226
Anti-GLA/alpha-Galactosidase A Antibody (4R472) 是一种 Rabbit 抗体，靶向 GLA/alpha-Galactosidase A。Anti-GLA/alpha-Galactosidase A Antibody (4R472) 可用于 ELISA,IP。
Anti-GLA/alpha-Galactosidase A Antibody (4R472)
Anti-GLA/alpha-Galactosidase A Antibody (4R472)
还可以产品编号 TMAY-02226
Anti-GLA/alpha-Galactosidase A Antibody (4R472) 是一种 Rabbit 抗体，靶向 GLA/alpha-Galactosidase A。Anti-GLA/alpha-Galactosidase A Antibody (4R472) 可用于 ELISA,IP。
产品信息正在更新中，如果您想购买，请点击大包装&定制按钮.
大包装 & 定制
联系我们获取更多批次信息
资源下载
产品介绍
生物活性
偶联与修饰
抗原信息
| 产品描述 | Anti-GLA/alpha-Galactosidase A Antibody (4R472) is a Rabbit antibody targeting GLA/alpha-Galactosidase A. Anti-GLA/alpha-Galactosidase A Antibody (4R472) can be used in ELISA,IP. |
| Ig Type | Monoclonal Rabbit IgG |
| 克隆号 | 4R472 |
| 交叉反应 | Human |
| 验证活性 | GLA was immunoprecipitated using: -Lane A:0.5 mg MCF-7 Whole Cell Lysate. -2 µL anti-GLA rabbit monoclonal antibody and 15 μl of 50 % Protein G agarose. -Primary antibody: -Anti-GLA rabbit monoclonal antibody, at 1:1000 dilution. -Secondary antibody: -Clean-Blotô IP Detection Reagent (HRP) at 1:1000 dilution. -Developed using the DAB staining technique. -Performed under reducing conditions. -Predicted band size: 49 kDa. -Observed band size: 52 kDa |
| 应用 | ELISA,IP |
| 推荐剂量 | ELISA: 1:5000-1:10000; IP: 4-6 μL/mg of lysate |
| 抗体种类 | Monoclonal |
| 宿主来源 | Rabbit |
| 构建方式 | This antibody was obtained from a rabbit immunized with purified, recombinant Human alpha-Galactosidase A / GLA (rh alpha-Galactosidase A / GLA; TMPY-01727; NP_000160.1; Met 1-Leu 429). |
| 纯化方式 | Protein A |
| 性状 | Liquid |
| 缓冲液 | 0.2 μm filtered solution in PBS |
| 研究背景 | Alpha-galactosidase A, also known as Alpha-D-galactoside galactohydrolase, Alpha-D-galactosidase A, Melibiase and GLA, is a member of the glycosyl hydrolase 27 family. GLA is used as a long-term enzyme replacement therapy in patients with a confirmed diagnosis of Fabry disease. Defects in GLA are the cause of Fabry disease (FD) which is a rare X-linked sphingolipidosis disease where glycolipid accumulates in many tissues. The disease consists of an inborn error of glycosphingolipid catabolism. FD patients show systemic accumulation of globotriaoslyceramide (Gb3) and related glycosphingolipids in the plasma and cellular lysosomes throughout the body. Clinical recognition in males results from characteristic skin lesions (angiokeratomas) over the lower trunk. Patients may show ocular deposits, febrile episodes, and burning pain in the extremities. Death results from renal failure, cardiac or cerebral complications of hypertension or other vascular disease. Deficiency of GLA leads to the accumulation of glycosphingolipids in the vasculature leading to multiorgan pathology. In addition to well-described microvascular disease, deficiency of GLA is also characterized by premature macrovascular events such as stroke and possibly myocardial infarction. |
| 偶联 | Unconjugated |
| 免疫原 | Recombinant Human alpha-Galactosidase A / GLA protein (TMPY-01727) |
| 抗原种属 | Human |
存储&运输
| 储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| 运输方式 | Shipping with blue ice. |
SCI 文献
计算器
比如您的给药剂量是 10 mg/kg ，每只动物体重 20 g ，给药体积 100 μL ， 
评论列表
预览
Related Tags: buy Anti-GLA/alpha-Galactosidase A Antibody (4R472) | purchase Anti-GLA/alpha-Galactosidase A Antibody (4R472) | Anti-GLA/alpha-Galactosidase A Antibody (4R472) cost | order Anti-GLA/alpha-Galactosidase A Antibody (4R472)
嗨！有任何问题？点我咨询
评论内容